Hücre Kültürü ve Toksikolojide Kullanımı

Authors

Yusuf Kurtulmuş
Caner Geyik
Nurdan Erkmen Sakallı

Synopsis

This section addresses the historical development of cell culture, its core operational principles, biosafety requirements, and its clinical and forensic applications in hepatic and renal toxicology. Beginning with Ross Granville Harrison's tissue culture studies in 1906, the field achieved a breakthrough in 1951 when Dr. George O. Gey derived the immortal HeLa cell line. Today, in vitro models play a critical role in understanding the metabolic and toxic effects of chemicals and pharmaceuticals in the human body by overcoming limitations caused by species-specific enzyme variations inherent to in vivo conditions. While primary hepatocytes, stem cell-derived hepatocyte-like cells (HLCs), and 3D culture models are utilized in liver toxicity assessments, proximal tubule cells and microfluidic systems feature prominently in renal toxicity studies. Furthermore, cell culture offers high efficiency, lower costs, and ease of automation in cosmetics, embryotoxicity, and the evaluation of cytotoxic and neurotoxic effects, as well as metabolite identification of emerging novel psychoactive substances (NPS) in forensic toxicology. Through 2D and 3D tissue engineering techniques, the architecture of target organs is mimicked, facilitating the acquisition of reliable and reproducible analytical data.

References

Ambrose CT. An amended history of tissue culture: Concerning Harrison, Burrows, Mall, and Carrel. J Med Biogr. 2019 May;27(2):95-102. doi: 10.1177/0967772016685033.

Ebeling AH. The effect of the variation in the osmotic tension and of the dülution of culture media on the cell proliferation of connective tissue. J Exp Med. 1914 Aug 1;20(2):130-9. doi: 10.1084/jem.20.2.130.

Lucké B. Characteristics of frog carcinoma in tissue culture. J Exp Med. 1939 Aug 31;70(3):269-76. doi: 10.1084/jem.70.3.269.

Porter KR, Claude A, Fullam EF. A study of tissue culture cells by electron microscopy: methods and preliminary observations. J Exp Med. 1945 Mar 1;81(3):233-46). doi: 10.1084/jem.81.3.233.

Philippeos C, Hughes RD, Dhawan A, Mitry RR. Introduction to cell culture. Methods Mol Biol. 2012;806:1-13. doi: 10.1007/978-1-61779-367-7_1.

Lucey BP, Nelson-Rees WA, Hutchins GM. Henrietta Lacks, HeLa cells, and cell culture contamination Arch Pathol Lab Med. 2009 Sep;133(9):1463-7. doi: 10.5858/133.9.1463,

LeCluyse EL, Alexandre E, Hamilton GA, et al. Isolation and Culture of Primary Human Hepatocytes. Methods Mol Biol. 2005;290:207-29. doi: 10.1385/1-59259-838-2:207

Maurel P. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Advanced Drug Delivery Reviews 1996;22:105-132.

Greenhough S, Medine CN, Hay DC. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. Toxicology 2010;278: 250–255.

Toyoda Y, Tamai M, Kashikura K, et al. Acetaminophen-Induced Hepatotoxicity in a Liver Tissue Model Consisting of Primary Hepatocytes Assembling around an Endothelial Cell Network Drug Metab Dispos. 2012 Jan;40(1):169-77. doi: 10.1124/dmd.111.041137.

Guguen-Guillouzo C, Corlu A, Guillouzo A. Stem cell-derived hepatocytes and their use in toxicology. . Toxicology. 2010 Mar 30;270(1):3-9. doi: 10.1016/j.tox.2009.09.019.

L'Eplattenier HF, Zhao JM, Pfannkuch F, et al. Cell culture in nephrotoxicity testing. Toxicol Lett. 1990 Sep;53(1-2):227-9. doi: 10.1016/0378-4274(90)90134-8.

Astashkina AI, Mann BK, Prestwich GD, Grainger DW. Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines. Biomaterials. 2012 Jun;33(18):4712-21. doi: 10.1016/j.biomaterials.2012.03.001.

Soo JY, Jansen J, Masereeuw R, Little MH. Advances in predictive in vitro models of drug-induced nephrotoxicity. Nat Rev Nephrol. 2018 Jun;14(6):378-393. doi: 10.1038/s41581-018-0003-9.

Gozalpour E, Fenner KS. Current State of in vitro Cell-Based Renal Models. Curr Drug Metab. 2018;19(4):310-326. doi: 10.2174/1389200219666180119115133.

Kuske B, Pulyanina PY, zur Nieden NI. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity. Methods Mol Biol. 2012;889:147-79. doi: 10.1007/978-1-61779-867-2_10.

Batistic F-K, Rhumorbarbe D, Lefrancois E, et al. Analysis of Google Trends to monitor new psychoactive substance. Is there an added value? Forensic Science International. Elsevier; 2021;326: 110918. doi:10.1016/J.FORSCIINT.2021.110918

Shafi A, Berry AJ, Sumnall H, et al. New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology. SAGE Publications Ltd STM; 2020;10: 2045125320967197. doi:10.1177/2045125320967197

Newton SC, Murphy LL, Bartke A. In vitro effects of psychoactive and non-psychoactive cannabinoids on immature rat sertoli cell function. Life Sciences. 1993;53(18): 1429–1437. doi:10.1016/0024-3205(93)90585-Q

Richter LHJ, Beck A, Flockerzi V, et al. Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay. Toxicology Letters. 2019;301: 79–89. doi:10.1016/j.toxlet.2018.11.007

Dias da Silva D, Ferreira B, Roque Bravo R, et al. The new psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone) induces oxidative stress, apoptosis, and autophagy in primary rat hepatocytes at human-relevant concentrations. Archives of Toxicology. 2019;93(9): 2617–2634. doi:10.1007/s00204-019-02539-x

Araújo AM, Carvalho M, Bastos M de L, et al. Metabolic signature of methylone in primary mouse hepatocytes, at subtoxic concentrations. Archives of Toxicology. 2019;93(11): 3277–3290. doi:10.1007/s00204-019-02566-8

Araújo AM, Bastos M de L, Fernandes E, et al. GC-MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA). Archives of Toxicology. 2018;92(11): 3307–3323. doi:10.1007/s00204-018-2314-9

Zwartsen A, Hondebrink L, Westerink RH. Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA). NeuroToxicology. 2018;66: 87–97. doi:10.1016/j.neuro.2018.03.007

Zwartsen A, Hondebrink L, Westerink RH. Changes in neuronal activity in rat primary cortical cultures induced by illicit drugs and new psychoactive substances (NPS) following prolonged exposure and washout to mimic human exposure scenarios. NeuroToxicology. 2019;74: 28–39. doi:10.1016/j.neuro.2019.05.004

Costa MA, Fonseca BM, Marques F, et al. The psychoactive compound of Cannabis sativa, Δ9-tetrahydrocannabinol (THC) inhibits the human trophoblast cell turnover. Toxicology. 2015;334: 94–103. doi:10.1016/j.tox.2015.06.005

Kim J, Koo B-K, Knoblich JA. Human organoids: model systems for human biology and medicine. Nature Reviews Molecular Cell Biology. 2020;21(10): 571–584. doi:10.1038/s41580-020-0259-3

Ao Z, Cai H, Havert DJ, et al. One-Stop Microfluidic Assembly of Human Brain Organoids To Model Prenatal Cannabis Exposure. Analytical Chemistry. American Chemical Society; 2020;92(6): 4630–4638. doi:10.1021/acs.analchem.0c00205

Rudin D, Liechti ME, Luethi D. Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology. 2021;343: 113778. doi:10.1016/j.expneurol.2021.113778

Gamage TF, Barrus DG, Kevin RC, et al. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018. Pharmacology Biochemistry and Behavior. 2020;193: 172918. doi:10.1016/j.pbb.2020.172918

Åstrand A, Guerrieri D, Vikingsson S, et al. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects. Forensic Science International. 2020;317: 110553. doi:10.1016/j.forsciint.2020.110553

Luethi D, Liechti ME. Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics. International Journal of Neuropsychopharmacology. 2018;21(10): 926–931. doi:10.1093/ijnp/pyy047

Manier SK, Felske C, Zapp J, et al. Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical Purposes. Journal of Analytical Toxicology. 2021;45(2): 195–202. doi:10.1093/jat/bkaa060

Manier SK, Felske C, Eckstein N, et al. The metabolic fate of two new psychoactive substances − 2-aminoindane and N-methyl-2-aminoindane − studied in vitro and in vivo to support drug testing. Drug Testing and Analysis. 2020;12(1): 145–151. doi:10.1002/dta.2699

Camille R, Thomas G, Chloe H, et al. In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl. Current Pharmaceutical Biotechnology. 2017;18(10): 806–814.

Richter LHJ, Flockerzi V, Maurer HH, et al. Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples. Journal of Pharmaceutical and Biomedical Analysis. 2017;143: 32–42. doi:10.1016/j.jpba.2017.05.028

Published

November 4, 2021

License

License